Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For MDXH.BR
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio 93.54 2.42 1.25
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -2308.25 -2.97 -0.12
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value -37.58 0.07 0.11
Cash -22.71 0.13 0.17
Capex 56.70 < 0.005 < 0.005
Free Cash Flow 35.95 -0.02 -0.03
Revenue 7.76 0.08 0.07
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin 8.74 0.65 0.60
Operating Margin 49.03 -0.24 -0.46
ROA 0.72 -0.07 -0.07
ROE -41.23 -0.56 -0.40
ROIC 5.65 -0.07 -0.08
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of MDXH.BR is permitted for members.
5 Growth
The "Growth Entry" for the Focus of MDXH.BR is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of MDXH.BR is permitted for members.